PAPSS1 inhibitors belong to a class of chemical compounds that have garnered attention in the field of molecular biology and cellular metabolism research. These inhibitors are specifically designed to target and modulate the activity of PAPSS1, which stands for 3'-phosphoadenosine 5'-phosphosulfate synthase 1. PAPSS1 is a key enzyme in the biosynthesis of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), a critical molecule involved in sulfonation reactions within cells. Sulfonation is a chemical modification process that attaches sulfate groups to various molecules, including hormones, drugs, and xenobiotics. PAPS serves as a universal sulfate donor in these reactions, facilitating the modification of a wide range of substrates and regulating their biological activity and elimination from the body.
PAPSS1 inhibitors exert their effects by interfering with the enzymatic activity or expression of PAPSS1, disrupting the biosynthesis of PAPS and sulfate conjugation reactions. This interference can lead to alterations in the sulfonation of various molecules, affecting their biological functions, metabolism, and clearance from the body. Researchers employ PAPSS1 inhibitors as valuable tools to investigate the specific roles of PAPSS1 in different cellular contexts and to gain insights into the molecular mechanisms governing sulfate conjugation and its implications for cellular metabolism and xenobiotic processing. While the precise applications and broader implications of PAPSS1 inhibitors are subjects of ongoing research, their utility in elucidating the complexities of sulfate conjugation reactions and their impact on cellular physiology and drug metabolism is of paramount importance in advancing our understanding of molecular and cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Blocks the translocation step in protein synthesis, potentially reducing PAPSS1 protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis and could decrease PAPSS1 mRNA levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Inhibits DNA-dependent RNA polymerase, potentially downregulating PAPSS1 gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically inhibits RNA polymerase II, possibly reducing transcription of the PAPSS1 gene. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Alkylates DNA and could crosslink the PAPSS1 gene, reducing its expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I and could prevent the replication and transcription of PAPSS1 DNA. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Incorporated into RNA, it may interfere with PAPSS1 mRNA processing and function. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, leading to depletion of guanine nucleotides and potentially reducing PAPSS1 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and can inhibit transcription of genes like PAPSS1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Intercalates into DNA and RNA, which may interfere with replication and transcription processes affecting PAPSS1 expression. | ||||||